Invention Grant
- Patent Title: Treatment of Fragile X Syndrome with cannabidiol
-
Application No.: US16986622Application Date: 2020-08-06
-
Publication No.: US11458110B2Publication Date: 2022-10-04
- Inventor: Marcel Bonn-Miller , Nancy Tich , Donna Gutterman , John Messenheimer , Terri Sebree
- Applicant: ZYNERBA PHARMACEUTICALS, INC.
- Applicant Address: US PA Devon
- Assignee: ZYNERBA PHARMACEUTICALS, INC.
- Current Assignee: ZYNERBA PHARMACEUTICALS, INC.
- Current Assignee Address: US PA Devon
- Agency: Womble Bond Dickinson (US) LLP
- Agent Danielle L. Herritt; Mark R. Deluca
- Main IPC: A61K36/00
- IPC: A61K36/00 ; A61K31/05 ; A61K36/185 ; A61P25/00 ; A61K9/00 ; A61K9/06
Abstract:
The present technology relates to a method of treating one or more behavioral symptoms of Fragile X Syndrome in a subject by transdermally administering an effective amount of cannabidiol (CBD) to the subject wherein one or more behavioral symptoms of Fragile X Syndrome are treated in the subject.
Information query
